EAAT-2 inhibitors (Neurocrine/Wyeth)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameEAAT-2 inhibitors (Neurocrine/Wyeth)
Drug Alias Nameexcitatory amino acid transporter inhibitors (Neurocrine/Wyeth)ATHD-IIIWAY-213394WAY-855ATHD-111 +[9] 
ClassificationSmall molecules
Mechanisms of ActionExcitatory amino acid transporter 2 inhibitorsNeuroprotectantsGlutamate metabolism modulators
TargetsExcitatory amino acid transporter 2
Therapy Area/IndicationsSchizophreniaNerve DegenerationStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeurocrine Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth Pharmaceuticals CoNeurocrine Biosciences Inc
Active IndicationsN/A
Inactive IndicationsSchizophreniaNerve DegenerationStroke

Other Information

ATC CodeN/A
Related LinksN/A